Fluvoxamine Helps Lower Risk of Hospitalization From Covid, Study Finds

October 27, 2021/in Uncategorized /by

Scientists say the results of the latest research examining the inflammation-fighting qualities of fluvoxamine, capping similar smaller studies, could lead to new treatment guidelines.

Call for more information

888-531-0245

info@siii-clinical.com

From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.

Get More Information